Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,641 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Covert Vascular Brain Injury and Cognitive Dysfunction Among Chinese Adults Living in Canada and China: The CAHHM and PURE-MIND Studies.
Ke C, Anand SS, Smith EE, Schulze KM, Moody A, Lear S, Poirier P, Dummer T, Desai D, Thayalasuthan V, Yusuf S, Teo KK, Wielgosz A, Lee D; as the Canadian Alliance of Healthy Hearts and Minds (CAHHM) and the Prospective Urban Rural Epidemiological (PURE) Study Investigators. Ke C, et al. Neurology. 2025 Feb 11;104(3):e210246. doi: 10.1212/WNL.0000000000210246. Epub 2025 Jan 9. Neurology. 2025. PMID: 39787476
A small cavity for detecting sound-induced flow.
Lai J, Liu Z, Karimi M, Farahikia M, Cui W, Pourghader J, Aghazadeh S, Ke C, Miles R. Lai J, et al. Among authors: ke c. J Acoust Soc Am. 2025 Jan 1;157(1):29-42. doi: 10.1121/10.0034788. J Acoust Soc Am. 2025. PMID: 39774913
A minimally invasive, fast on/off "Odorgenetic" method to manipulate physiology.
Wu Y, Xu X, Su S, Yang Z, Hao X, Lu W, He J, Hu J, Li X, Yu H, Yu X, Xiao Y, Lu S, Wang L, Tian W, Xiang H, Cao G, Tu WJ, Ke C. Wu Y, et al. Among authors: ke c. Protein Cell. 2024 Dec 31:pwae072. doi: 10.1093/procel/pwae072. Online ahead of print. Protein Cell. 2024. PMID: 39738522 Free article. No abstract available.
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Yang BF, et al. Among authors: ke cx. Expert Rev Vaccines. 2025 Dec;24(1):81-90. doi: 10.1080/14760584.2024.2446288. Epub 2025 Jan 5. Expert Rev Vaccines. 2025. PMID: 39720838 Free article. Clinical Trial.
1,641 results